
Lilly’s Q1 2024 Financials: Boosts Full-Year Revenue Projection by $2B, Highlights Pipeline Momentum
Eli Lilly and Company (NYSE: LLY) unveiled its financial performance for the first quarter of 2024 today. David A. Ricks, Lilly’s chair and CEO, commented on the company’s robust year-over-year revenue growth, attributing it to strong sales of Mounjaro and…